Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Mind Medicine MindMed Inc. diskutieren

Mind Medicine MindMed Inc.

WKN: A3DR6E / Symbol: MNMD / Name: Mind Medicine MindMed / Aktie / Small Cap /

12,89 €
0,08 %

Einschätzung Buy
Rendite (%) -8,63 %
Kursziel 32,27
Veränderung
Endet am 31.07.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 42,59 %
Kursziel 49,60
Veränderung
Endet am 29.08.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target raised by analysts at HC Wainwright from $35.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 119,78 %
Kursziel 18,33
Veränderung
Endet am 14.10.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $20.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 24,52 %
Kursziel 51,65
Veränderung
Endet am 11.11.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 45,77 %
Kursziel 19,04
Veränderung
Endet am 17.12.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $20.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 61,15 %
Kursziel 19,21
Veränderung
Endet am 20.12.25

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Der Beitrag wird untersucht

Thank you for the latest update on stock Geometry Dash Lite fluctuations. I find it very useful.

Einschätzung Buy
Rendite (%) 89,70 %
Kursziel 22,05
Veränderung
Endet am 28.01.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 86,14 %
Kursziel 52,97
Veränderung
Endet am 31.01.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

@BrigitteParisian I want to know the exact capybara clicker
fluctuation.

Einschätzung Buy
Rendite (%) 115,91 %
Kursziel 50,69
Veränderung
Endet am 07.03.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 104,28 %
Kursziel 14,72
Veränderung
Endet am 07.03.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target lowered by analysts at Robert W. Baird from $27.00 to $16.00. They now have an "outperform" rating on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 122,24 %
Kursziel 17,83
Veränderung
Endet am 09.05.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 65,36 %
Kursziel 21,60
Veränderung
Endet am 04.08.26

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,50 %
Kursziel 17,33
Veränderung
Endet am 07.11.26

Mind Medicine (MindMed) (NASDAQ:MNMD) had its price target lowered by analysts at Royal Bank Of Canada from $21.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for MNMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,64 %
Kursziel 51,81
Veränderung
Endet am 23.12.26

Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Jones Trading. They set a "buy" rating and a $61.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat